Overview

Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Status:
Completed

Trial end date:
2014-02-27

Target enrollment:

Participant gender:

Summary

This is a single-dose study to evaluate the pharmacokinetics, safety, and tolerability of icatibant administered to adult Japanese subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Shire

Treatments:

Analgesics
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Bradykinin
Icatibant
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents